FDA Approves Klygefa (gefurulimab) for the Treatment of Generalised Myasthenia Gravis

Nov 17, 2026 - 02:00
 0  0
16 November 2026 -- Alexion, AstraZeneca Rare Disease’s Klygefa (gefurulimab) has been approved in the US for the treatment of generalised myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0